Peer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and Their Caregivers

City of Hope

Status: Terminated

Conditions: Vulvar Carcinoma; Uterine Corpus Cancer; Ovarian Carcinoma; Vaginal Carcinoma; Cervical Carcinoma

Treatments: Other: Quality-of-Life Assessment; Other: Questionnaire Administration; Procedure: Supportive Care

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT02412124

14359

NCI-2015-00467 (Registry Identifier)

Details and patient eligibility

About

This pilot clinical trial studies a peer-to-peer support program in improving quality of life outcomes in patients with gynecologic cancer and their caregivers. Peer-to-peer support and mentoring may help improve quality of life and reduce symptoms of distress in gynecologic cancer patients and their families.

Full description

PRIMARY OBJECTIVES:

I. To test the feasibility and acceptability of a Woman-to-Woman (W2W) program for patients with gynecologic cancer at City of Hope (COH). Address the following descriptive research questions: were patients, mentors, and patients' family caregivers satisfied with the timing, format, and content of the program? Did the program benefit patients, mentors, and patients' family caregivers?

OUTLINE:

Patients participate in the W2W program for which they are matched with a trained mentor and followed throughout treatment by phone, email, and/or in person.

After completion of study, patients are followed up at 6 and 12 months.

Enrollment: 3 patients

Sex: Female

Ages: 19+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• PATIENT PARTICIPANTS
• Patients with newly diagnosed or recurrent gynecologic cancer (ovarian, uterine, cervical, vaginal, vulvar) actively undergoing treatment (chemotherapy, surgery, or radiation therapy) at COH (including Duarte and South Pasadena campuses)
• English-speaking patients
• PEER MENTORS
• Peer mentors will be past gynecologic cancer patients not currently undergoing treatment for their cancer, and considered without evidence of disease
• Over age 18
• PEER MENTORS: English-speaking patients
• This study is open to patients of all races and ethnicities

Exclusion criteria

• PEER MENTORS:
• Major psychiatric disease
• Currently undergoing treatment for active gynecologic cancer

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

3 participants in 1 patient group

Supportive care (W2W program)

Experimental group

Description:

Patients participate in the W2W program for which they are matched with a trained mentor and followed throughout treatment by phone, email, and/or in person.

Treatment:

Other: Questionnaire Administration

Procedure: Supportive Care

Other: Quality-of-Life Assessment